GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,082,703 | -36.9% | 1,129,561 | -24.3% | 0.20% | -33.2% |
| Q2 2023 | $88,844,754 | +2.9% | 1,492,186 | -2.1% | 0.30% | -0.7% |
| Q1 2023 | $86,317,094 | -23.7% | 1,523,960 | +0.0% | 0.30% | -27.2% |
| Q4 2022 | $113,169,507 | -37.0% | 1,523,758 | -49.4% | 0.41% | +15.6% |
| Q3 2022 | $179,497,281 | +5.3% | 3,013,204 | -0.7% | 0.35% | +11.7% |
| Q2 2022 | $170,417,674 | -26.8% | 3,035,578 | -3.8% | 0.32% | -4.5% |
| Q1 2022 | $232,859,414 | +93.6% | 3,156,124 | +89.5% | 0.33% | +7.8% |
| Q4 2021 | $120,259,000 | +2.5% | 1,665,627 | +8.8% | 0.31% | -6.7% |
| Q3 2021 | $117,299,000 | -48.6% | 1,530,920 | -48.0% | 0.33% | +0.3% |
| Q2 2021 | $228,226,000 | +140.1% | 2,943,728 | +91.0% | 0.33% | +13.5% |
| Q1 2021 | $95,038,000 | +9.4% | 1,541,062 | +15.7% | 0.29% | +5.9% |
| Q4 2020 | $86,880,000 | +27.4% | 1,332,101 | -3.3% | 0.27% | +11.0% |
| Q3 2020 | $68,195,000 | -51.0% | 1,377,132 | -52.8% | 0.25% | -10.2% |
| Q2 2020 | $139,226,000 | +19.1% | 2,918,184 | +6.1% | 0.27% | -6.2% |
| Q1 2020 | $116,934,000 | -18.6% | 2,749,420 | +12.7% | 0.29% | 0.0% |
| Q4 2019 | $143,682,000 | +81.0% | 2,440,248 | +57.1% | 0.29% | +84.8% |
| Q3 2019 | $79,396,000 | +16.3% | 1,553,124 | -3.8% | 0.16% | +17.9% |
| Q2 2019 | $68,272,000 | +54.7% | 1,614,006 | +80.7% | 0.13% | -22.1% |
| Q1 2019 | $44,136,000 | +13.1% | 893,253 | -0.9% | 0.17% | +1.2% |
| Q4 2018 | $39,026,000 | -26.8% | 901,699 | -4.0% | 0.17% | -12.8% |
| Q3 2018 | $53,289,000 | +4.8% | 938,832 | -6.8% | 0.20% | 0.0% |
| Q2 2018 | $50,833,000 | +3.6% | 1,007,392 | +2.3% | 0.20% | -0.5% |
| Q1 2018 | $49,083,000 | +28.4% | 985,200 | +5.9% | 0.20% | +30.7% |
| Q4 2017 | $38,223,000 | +71.0% | 930,009 | +23.6% | 0.15% | +56.2% |
| Q3 2017 | $22,356,000 | -0.1% | 752,206 | +11.4% | 0.10% | -5.9% |
| Q2 2017 | $22,386,000 | +7.0% | 675,281 | -4.4% | 0.10% | +8.5% |
| Q1 2017 | $20,921,000 | +47.0% | 706,324 | +23.1% | 0.09% | +40.3% |
| Q4 2016 | $14,236,000 | – | 573,786 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |